Covalon Technologies Ltd. COV.V Stock
Covalon Technologies Ltd. Price Chart
Covalon Technologies Ltd. COV.V Financial and Trading Overview
Covalon Technologies Ltd. stock price | 1.1 CAD |
Previous Close | 1.94 CAD |
Open | 1.94 CAD |
Bid | 1.75 CAD x 0 |
Ask | 2 CAD x 0 |
Day's Range | 1.94 - 1.94 CAD |
52 Week Range | 1.71 - 2.74 CAD |
Volume | 500 CAD |
Avg. Volume | 4.65K CAD |
Market Cap | 47.99M CAD |
Beta (5Y Monthly) | 0.967291 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.19 CAD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
COV.V Valuation Measures
Enterprise Value | 39.09M CAD |
Trailing P/E | N/A |
Forward P/E | 6.4666667 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.0555954 |
Price/Book (mrq) | 2.1797755 |
Enterprise Value/Revenue | 1.674 |
Enterprise Value/EBITDA | -6.604 |
Trading Information
Covalon Technologies Ltd. Stock Price History
Beta (5Y Monthly) | 0.967291 |
52-Week Change | -24.51% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.74 CAD |
52 Week Low | 1.71 CAD |
50-Day Moving Average | 2.01 CAD |
200-Day Moving Average | 2.21 CAD |
COV.V Share Statistics
Avg. Volume (3 month) | 4.65K CAD |
Avg. Daily Volume (10-Days) | 4.45K CAD |
Shares Outstanding | 24.74M |
Float | 12.6M |
Short Ratio | 1.09 |
% Held by Insiders | 56.62% |
% Held by Institutions | 0% |
Shares Short | 5.17K |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.020% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | -28.97% |
Operating Margin (ttm) | -28.70% |
Gross Margin | 48.51% |
EBITDA Margin | -25.35% |
Management Effectiveness
Return on Assets (ttm) | -13.40% |
Return on Equity (ttm) | -26.33% |
Income Statement
Revenue (ttm) | 23.35M CAD |
Revenue Per Share (ttm) | 0.92 CAD |
Quarterly Revenue Growth (yoy) | 119.90% |
Gross Profit (ttm) | 7.49M CAD |
EBITDA | -5919810 CAD |
Net Income Avi to Common (ttm) | -6763303 CAD |
Diluted EPS (ttm) | -0.27 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 10.77M CAD |
Total Cash Per Share (mrq) | 0.44 CAD |
Total Debt (mrq) | 1.87M CAD |
Total Debt/Equity (mrq) | 8.43 CAD |
Current Ratio (mrq) | 5.434 |
Book Value Per Share (mrq) | 0.89 |
Cash Flow Statement
Operating Cash Flow (ttm) | -8130883 CAD |
Levered Free Cash Flow (ttm) | -4776392 CAD |
Profile of Covalon Technologies Ltd.
Country | Canada |
State | ON |
City | Mississauga |
Address | 1660 Tech Avenue |
ZIP | L4W 5S7 |
Phone | 905 568 8400 |
Website | https://www.covalon.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has three proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. Its products include wound care dressings; surgical and peri-operative; and infection management products. The company offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.
Q&A For Covalon Technologies Ltd. Stock
What is a current COV.V stock price?
Covalon Technologies Ltd. COV.V stock price today per share is 1.1 CAD.
How to purchase Covalon Technologies Ltd. stock?
You can buy COV.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Covalon Technologies Ltd.?
The stock symbol or ticker of Covalon Technologies Ltd. is COV.V.
Which industry does the Covalon Technologies Ltd. company belong to?
The Covalon Technologies Ltd. industry is Biotechnology.
How many shares does Covalon Technologies Ltd. have in circulation?
The max supply of Covalon Technologies Ltd. shares is 24.67M.
What is Covalon Technologies Ltd. Price to Earnings Ratio (PE Ratio)?
Covalon Technologies Ltd. PE Ratio is now.
What was Covalon Technologies Ltd. earnings per share over the trailing 12 months (TTM)?
Covalon Technologies Ltd. EPS is -0.19 CAD over the trailing 12 months.
Which sector does the Covalon Technologies Ltd. company belong to?
The Covalon Technologies Ltd. sector is Healthcare.